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Abstract
Background: Oliguria is one of the leading triggers of fluid loading in patients in the intensive care unit (ICU). The
purpose of this study was to assess the predictive value of urine Na+ (uNa+) and other routine urine biomarkers for
cardiac fluid responsiveness in oliguric ICU patients.
Methods: We conducted a prospective multicenter observational study in five university ICUs. Patients with urine
output (UO) <0.5 ml/kg/h for 3 consecutive hours with a mean arterial pressure >65 mmHg received a fluid
challenge. Cardiac fluid responsiveness was defined by an increase in stroke volume >15 % after fluid challenge.
Urine and plasma biochemistry samples were examined before fluid challenge. We examined renal fluid
responsiveness (defined as UO >0.5 ml/kg/h for 3 consecutive hours) after fluid challenge as a secondary endpoint.
Results: Fifty-four patients (age 51 ± 37 years, Simplified Acute Physiology Score II score 40 ± 20) were included.
Most patients (72 %) were not cardiac responders (CRs), and 50 % were renal responders (RRs) to fluid challenge.
Patient characteristics were similar between CRs and cardiac nonresponders. uNa+ (37 ± 38 mmol/L vs 25 ±
75 mmol/L, p = 0.44) and fractional excretion of sodium (FENa+) (2.27 ± 2.5 % vs 2.15 ± 5.0 %, p = 0.94) were not
statistically different between those who did and those who did not respond to the fluid challenge. Areas under
the receiver operating characteristic (AUROC) curves were 0.51 (95 % CI 0.35–0.68) and 0.56 (95 % CI 0.39–0.73) for
uNa+ and FENa+, respectively. Fractional excretion of urea had an AUROC curve of 0.70 (95 % CI 0.54–0.86, p = 0.03)
for CRs. Baseline UO was higher in RRs than in renal nonresponders (1.07 ± 0.78 ml/kg/3 h vs 0.65 ± 0.53 ml/kg/3 h,
p = 0.01). The AUROC curve for RRs was 0.65 (95 % CI 0.53–0.78) for uNa+.
Conclusions: In the present study, most oliguric patients were not CRs and half were not renal responders to fluid
challenge. Routine urinary biomarkers were not predictive of fluid responsiveness in oliguric normotensive ICU
patients.
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Background
In the intensive care unit (ICU), oliguria is one of the
first variables leading to a fluid challenge [1]. Al-
though several physiological parameters may predict
fluid responsiveness (e.g., increase in stroke volume
after fluid challenge), most cannot be applied in ICU
patients because criteria for validity are not met [2].
In addition, measurement of cardiac output is infre-
quent. As a result, at the bedside, fluid responsiveness
remains difficult to assess [3]. In routine practice, oli-
guria is one of the leading conditions triggering the
decision to apply fluid challenge [1]. This probably re-
flects the belief that oliguria is an accurate marker of
hypovolemia.
A positive cumulative fluid balance has been associ-
ated with poor outcome, especially in patients with acute
kidney injury (AKI) [4]. Hence, there is still a need for
markers to predict fluid responsiveness in order to avoid
an overload of fluid loading. Low urine Na+ concentration
(uNa+) has long been considered a biomarker of a low
intravascular volume state [5]. However, many factors
may lead to renin-angiotensin-aldosterone system (RAAS)
activation or alteration of intrarenal hemodynamics affect-
ing uNa+ independently of intravascular volume [6]. How-
ever, the predictive value of uNa+ has never been assessed
in ICU patients. We therefore conducted this study to
evaluate the value of uNa+ for cardiac fluid responsiveness
in normotensive, oliguric ICU patients. We also examined
the renal responsiveness (i.e., urine output) after a fluid
challenge as a secondary endpoint.
Methods
Because this study was observational and did not
change daily practice, the institutional review board of
the University Hospital of Paris North (IRB00003835)
approved the present study (protocol 2013/47NICB)
and waived the requirement for obtaining written
consent. However, the patients’ next of kin were sys-
tematically orally informed and could refuse patient
participation. Moreover, the patients were later, and as
soon as possible, systematically informed and could re-
fuse use of their data.
Patient selection
This study was performed in five university hospital
ICUs. Patients were included if they met the following
criteria:
1. They met criteria for oliguria, defined by
urine output <0.5 ml/kg/h for 3 consecutive
hours [7].
2. The administration of a fluid challenge (500 ml of
isotonic crystalloids over 15 minutes) was indicated
by the physician in charge.
3. Their mean arterial pressure was >65 mmHg and
without significant change in norepinephrine dose
(<20 %) during the last 3 h.
4. They did not receive diuretics on the day of inclusion.
Physicians were asked to explain the indications for
fluid challenge. The exclusion criteria were patients
under 18 years old, patients treated with diuretics, pa-
tients with stage 3 AKI, pregnancy, patients in whom a
decision to withhold or withdraw treatment had been
made, moribund patients, and patients who refused to
participate.
Measurements
The main endpoint of the study was fluid responsive-
ness, defined as an increase in stroke volume >15 % at
the end of the fluid challenge. Patients were classified as
cardiac responders (CRs) or cardiac nonresponders
(CNRs) accordingly. Secondary endpoints included renal
fluid responsiveness, defined as a post-fluid challenge
urine output >0.5 ml/kg/h for more than 3 h (fluid renal
responders [RRs]). Patient characteristics, Simplified
Acute Physiology Score II (SAPS II) at admission, and
reasons for ICU admission were recorded. At inclusion
(i.e., at the time of oliguria diagnosis; urine output
<0.5 ml/kg/h for 3 consecutive hours), we collected
blood and urine samples, performed routine laboratory
measurements, and recorded urine output during the
previous 3 and 6 h.
Baseline serum creatinine (Screat) level was determined
from blood samples taken on admission. In cases where
the baseline creatinine plasma level or estimated glomeru-
lar filtration rate (eGFR) was not available, the baseline
creatinine plasma level was estimated by using the Modifi-
cation of Diet in Renal Disease equation with a normal
eGFR value of 75 ml/minute/1.73 m2. New onset of AKI
was defined as (1) an increase in Screat level 26.5 mol/L
within 48 h or increase in SCreat to 1.5 times base-
line ≥26 μmol/L or >50 % compared with baseline
value or (2) need for renal replacement therapy (RRT) [8].
Blood and urine analysis
Urine samples were immediately analyzed in the central
laboratory of each participating center for uNa+, urine
creatinine concentration, urine urea concentration
(uUrea), and potassium concentration. Screat, Na+, po-
tassium, urea, and chloride were measured at the same
time, allowing calculation of fractional excretion of so-
dium (FENa+), fractional excretion of urea (FEurea), and
urine/plasma creatinine.
Statistical analysis
Using fluid responsiveness as the main endpoint, we
estimated that an area under the receiver operating
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characteristic (AUROC) curve of uNa+ would be clinically
relevant if the 95 % CI of its AUROC curve was >0.75,
corresponding to a good AUROC [9, 10]. Inclusion of ≥40
patients was therefore necessary to show an AUROC
curve of uNa+ >0.85 with 95 % CI >0.75 based on an esti-
mation of 50 % of patients being fluid responders.
Categorical variables were compared using a χ2 test.
The marginal association of biomarkers with fluid re-
sponsiveness was studied using the Mann-Whitney U
test. The AUROC curve to predict fluid responsiveness
was built for urine biochemistry biomarkers. We deter-
mined the optimal threshold value using the “closest top
left” method. All analyses were performed using IBM
SPSS Statistics software (IBM, Armonk, NY, USA).
All p values were two-tailed, and a p value <0.05 was
considered significant. Values are expressed as num-




Fifty-four patients were included (age 64 ± 19 years, n = 22
females, SAPS II score 38 ± 17) between March 2014 and
March 2015. The patient features are shown in Table 1.
Reasons for ICU admission were sepsis, neurological
disorders, acute respiratory failure, and trauma/burns. At
inclusion, seven patients (13 %) were being treated with
antibiotics.
Fluid challenge
Stroke volume was measured using calibrated pulse
pressure signal analysis (n = 13), ultrasound-derived ana-
lysis (transesophageal Doppler; n = 17), or echocardiog-
raphy (n = 24). Before fluid challenge, only cardiac
output and central venous oxygen saturation were lower
in the CRs than in the CNRs (Table 1). Pulse pressure var-
iations were similar in the CRs and the CNRs (14 ± 19 %
vs 6 ± 11 %, p = 0.18). During the inclusion day, the CRs
and the CNRs received 1543 ± 1415 ml and 2253 ±
2381 ml of fluid, respectively (p = 0.28).
Biomarkers to predict fluid responsiveness
Cardiac response
Fifteen patients (27 %) were CRs to the fluid chal-
lenge. Baseline urine output (0.76 ± 0.90 ml/kg/3 h vs
0.94 ± 0.69 ml/kg/3 h, p = 0.55), Urine soidium ( uNa+ 37
± 38 mmol/L vs 25 ± 75 mmol/L, p = 0.88), and FENa+
(2.3 ± 2.5 % vs 2.2 ± 5.0 %, p = 0.40) were similar in
the CRs and the CNRs, corresponding to AUROC
curves for predicting fluid responsiveness of 0.51
(95 % CI 0.35–0.68) and 0.56 (95 % CI 0.39-0.73), re-
spectively, for uNai and FENa+ (Fig. 1). uNa+
<20 mmol/L and FENa+ <1 % had sensitivities of 40 % and
93 %, respectively, and specificities of 61 % and 41 %,
respectively, to predict the cardiac response. FEurea (17 ±
17 % vs 26 ± 16 %, p = 0.036) and uUrea (200 ± 154 mmol/
L vs 299 ± 214 mmol/L, p = 0.04) were less in the CRs
than in the CNRs (Fig. 2), corresponding to AUROC
curves of 0.70 (95 % CI 0.54–0.86, p = 0.03) and 0.68
(95 % CI 0.53–0.84, p = 0.06), respectively (Fig. 2).
Renal response
Twenty-seven patients (50 %) were RRs to the fluid chal-
lenge. These changes persisted 6 h after the fluid chal-
lenge. Baseline urine output was 1.07 ± 0.78 ml/kg/3 h in
the RRs and 0.65 ± 0.53 ml/kg/3 h in the renal nonre-
sponders (p = 0.01). The AUROC curves for predicting
renal fluid responsiveness were 0.65 (95 % CI 0.53–0.78)
for uNa+, 0.57 (95 % CI 0.41–0.73) for FENa+, and 0.61
(95 % CI 0.45–0.77) for FEUrea. Urine output increased
to 1.03 ± 1.67 ml/kg/3 h in CRs and to 1.81 ± 1.38 ml/
kg/3 h in CNRs (p = 0.03 and p < 0.001, respectively)
compared with baseline during the 3 h after the fluid
challenge (Fig. 3).
Outcome
Twenty-one patients developed AKI, including seven
patients (13 %) requiring RRT (p > 0.05 between fluid
responders and fluid nonresponders). Eleven patients
(21 %) died during their ICU stay (p > 0.05 between CRs
and CNRs).
Discussion
In our study, most patients with transient oliguria did
not increase their cardiac output or their urine output
after the fluid challenge. Low urine sodium concentration
and FENa+ were not reliable predictors of fluid respon-
siveness. Although FEurea and uUrea were different in the
CRs and the CNRs, the differences were not clinically rele-
vant for predicting fluid responsiveness.
In routine practice, low urine output often leads to
performing fluid challenge in ICU patients. This is based
on the hypothesis of a systemic hemodynamic con-
tribution to low renal blood flow and low urine output
[11, 12]. However, physiological grounds exist to con-
sider oliguria a poor marker of hypovolemia or low
intravascular volume [6]. Shock, pain, and the periopera-
tive period are associated with alteration of intrarenal
hemodynamics [13, 14] and activation of the RAAS,
leading to antinatriuresis and antidiuresis [15, 16]. Our
study shows that oliguria with low urine Na+ concentra-
tion in normotensive ICU patients may not reflect hypo-
volemia in a large proportion of patients. Hence, fluid
challenge may not translate into an increase in cardiac
output or urine output.
Low uNa+ has long been proposed as a biomarker of
prerenal failure as well as low intravascular volume
status and/or low cardiac output. However, a low urine
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Table 1 Patient characteristics
Characteristic All patients (n = 54) Cardiac responders (n = 15) Cardiac nonresponders (n = 39) p Value
Age, years 64 (55–73) 66 (54– 78) 63 (54–72) 0.93
Male sex, n (%) 32 (59) 8 (53) 23 (59) 0.73
Comorbidities, n (%)
COPD 8 (15) 3 (20) 5 (13) 0.67
Diabetes mellitus 8 (15) 2 (13) 6 (15) 1.0
Hypertension 23 (42) 7 (47) 16 (41) 0.76
Heart failure 8 (15) 5 (33) 3 (8) 0.03
Cancer 11 (20) 4 (27) 7 (18) 0.47
Nephrotoxic agents
NSAIDs 1 (2) 0 (0) 1 (3) 1.0
ACE inhibitors 2 (4) 0 (0) 2 (5) 1.0
Aminoglycosides 9 (17) 2 (13) 7 (18) 1.0
Contrast media 12 (22) 16 (23) 9 (23) 1.0
Organ failure
Mechanical ventilation, n (%) 33 (42) 10 (67) 23 (59) 0.77
SAPS II score 39 (30–48) 38 (25–51) 39 (30–48) 0.92
Norepinephrine, n (%) 17 (31) 6 (40) 11 (28) 0.52
Lactate, mmol/L 1.8 (1.3–2.3) 1.9 (0.9–2.8) 1.7 (1.3–2.2) 0.39
Blood urea nitrogen, mmol/L 12 (8–17) 11 (7–15) 13 (8–18) 0.93
Serum creatinine, μmol/L 90 (56–124) 117 (81–153) 74 (49–99) 0.22
Bilirubin, mg/L 7 (1–14) 9 (5–13) 7 (1–13) 1.00
Bicarbonate, mmol/L 25 (22–28) 21 (17–25) 26 (23–29) 0.06
Platelet count, 103/L 346 (201–491) 207 (95–319) 358 (215–501) 1.00
Hemoglobin, g/dl 9.4 (8.1–10.7) 10.4 (8.4–12.4) 9.1 (8.1–10.1) 0.54
Glucose, mmol/L 7.9 (7.0–8.8) 7.9 (7.1–8.6) 8.0 (6.9–9.1) 0.73
Reason for ICU admission
Sepsis 14 (26) 2 (13) 12 (31) 0.3
Neuro-ICU 5 (9) 2 (13) 3 (8) 0.61
Respiratory failure 13 (24) 1 (7) 12 (31) 0.08
Trauma/hemorrhage 7 (13) 2 (13) 5 (13) 1.0
Cardiogenic shock 1 (2) 0 (0) 1 (3) 1.0
Post-cardiac arrest 4 (7) 2 (13) 2 (5) 0.3
Hemodynamic status
SAP, mmHg 134 (118–150) 112 (104–120) 138 (126–150) 0.92
MAP, mmHg 81 (71–91) 74 (67–81) 87 (79–95) 0.07
HR, beats/minute 98 (85–111) 98 (82–114) 96 (81–111) 0.14
CO, L/minute 5.3 (2.8–7.8) 4.9 (1.7–8.1) 5.6 (3.3–7.9) 0.07
ScvO2, % 75 (62–88) 66 (54–78) 85 (75–95) 0.01
CVP, mmHg 8 (6–10) 8 (7–9) 7 (4–10) 0.58
Abbreviations: ICU intensive care unit, COPD chronic obstructive pulmonary disease, CAD coronary artery disease, NSAIDs nonsteroidal anti-inflammatory drugs, ACE
angiotensin-converting enzyme, SAPS II Simplified Acute Physiology Score II, SAP systolic arterial pressure, MAP mean arterial pressure, HR heart rate, CO cardiac
output, CVP central venous pressure, ScvO2 central venous oxygen saturation
Data are expressed as absolute number (percentage) or median (interquartile range)
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Na+ concentration is a biomarker of RAAS activation
that may be triggered by various factors. Urine bio-
markers have previously been shown to inaccurately pre-
dict persistent or transient AKI [17]. In a multicenter
study, Pons et al. showed that urine biochemistry param-
eters, including FENa+ and FEurea, did not predict the
rapid reversibility of AKI [18]. Regulation of urine out-
put and renal Na+ handling involves many other factors,
including tubular cell function and systemic inflamma-
tion [19, 20]. Therefore, many factors unrelated to intra-
vascular volume and cardiac output may affect urine
output and renal Na+ handling, including tubular Na+
Fig. 1 Box plots representing urine Na+, serum creatinine, urine urea, and fractional excretion of urea (FEurea) at the time of oliguria recognition,
according to cardiac fluid responsiveness
Fig. 2 a Receiver operating characteristic curves of urine urea (uUrea) and fractional excretion of urea (FEurea). b Receiver operating characteristic
curves of urine Na + (uNa+) and fractional excretion of Na + (FENa+) at the time of oliguria recognition to predict cardiac fluid responsiveness.
Data are expressed as median (95 % CI)
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channel expression [6]. It therefore remains very difficult
to recommend the use of urinary biomarkers to predict
fluid responsiveness in critically ill patients. Urine bio-
markers may still be indicative of tubular function and
renal hemodynamics, but these points were not ad-
dressed in the present study. In our study, the influence
of renal perfusion pressure on renal hemodynamics was
reduced by excluding the patients with mean arterial
pressure <65 mmHg. However, urine Na+ remained
poorly predictive of fluid responsiveness (either cardiac
output or renal response) in our patients. Clinicians
should therefore rely on other markers of fluid responsive-
ness when deciding whether to initiate a fluid challenge in
patients with oliguria. Nevertheless, we acknowledge that
our definition of renal responsiveness was arbitrary, rely-
ing on the Kidney Disease: Improving Global Outcomes
(commonly referred to as KDIGO [21]) definition with a
urine output threshold of 0.5 ml/kg/h. Some patients
showed a relative increase of urine output after the fluid
challenge, albeit below this threshold.
Our study has several limitations. First, the sample size
was small. However, the sample size was sufficient to
detect a good predictive value of the biomarker. This
hypothesis can be rejected on the basis of our results.
The low rate of inclusion could be explained by several
factors. Our patients had to be both oliguric and
hemodynamically stabilized, which may have limited the
number of patients eligible for inclusion. Second, they
had to be off drugs that interact with renal sodium
handling (e.g., diuretics). Third, monitoring of cardiac
output or an echocardiography-certified physician was
required to monitor stroke volume during the fluid chal-
lenge. Altogether, these points may limit the external
validity of the results. Nevertheless, urine Na+ was not
strongly associated with fluid responsiveness. A poor
predictive value for fluid responsiveness was observed.
Stroke volume was evaluated with different tools.
These tools have been used with acceptable accuracy in
monitoring stroke volume [2]. Most important, the same
monitor was used for each patient, limiting bias. Urine
Fig. 3 Evolution of urine output (UO) between 3 h before and after fluid challenge, respectively, in renal responders (a), renal nonresponders (b),
cardiac responders (c), and cardiac nonresponders (d)
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biochemistry analyses were not centralized in a single la-
boratory. This may have generated variability, but it also
increased the extrapolation of our results. Norepineph-
rine infusion was required in some patients, affecting
intrarenal hemodynamics. However, Bellomo et al. ob-
served that restoring renal perfusion pressure with nor-
epinephrine decreased renal resistance and increased
renal conductance in sepsis [22]. Finally, regarding the
AKI definition, we were aware that estimating baseline
serum creatinine may have introduced bias into the classi-
fication. However, estimation of baseline serum creatinine
in ICU patients with no available baseline values remains
a challenge, with no consensus on the method of obtain-
ing a surrogate.
Conclusions
In the present study, most oliguric patients were not
cardiac responders and half were not renal responders
to fluid challenge. Routine urinary biomarkers were not
predictive of fluid responsiveness in oliguric, normoten-
sive ICU patients.
Key messages
 Most ICU normotensive patients with oliguria do
not respond to fluid challenge.
 Urine Na + and urea concentration are not reliable
biomarkers of fluid responsiveness in oliguric ICU
patients.
 Excessive reliance on oliguria and urine biomarkers
may lead to excessive fluid loading with potentially
harmful consequences.
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